ExodusPoint Capital Management »

Monte Rosa Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 265k 7.05
2023-09-30 $3.0M 619k 4.79
2023-06-30 $4.6M 670k 6.85
2023-03-31 $2.0M 262k 7.79

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Meta Platforms Cl A (META)
Global Payments (GPN)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NiSource (NI)
PPL Corporation (PPL)
Intel Corporation (INTC)
Marvell Technology (MRVL)
Exxon Mobil Corporation (XOM)

View all positions for ExodusPoint Capital Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
FMR
T. Rowe Price Associates
Baker Bros. Advisors
venBio Select Advisor
BlackRock
Vanguard Group
Aisling Capital Management
Alphabet
Citadel Advisors
Geode Capital Management
State Street Corporation
Casdin Capital
Northern Trust
ExodusPoint Capital Management

View all funds holding Monte Rosa Therapeutics